282 related articles for article (PubMed ID: 27197965)
21. Family history is significantly associated with prostate cancer and its early onset in Chinese population.
Xu Y; Huang D; Wu Y; Ye D; Zhang N; Gao Y; Xu D; Na R; Xu J
Prostate; 2019 Nov; 79(15):1762-1766. PubMed ID: 31497879
[TBL] [Abstract][Full Text] [Related]
22. Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification.
Weigl K; Hsu L; Knebel P; Hoffmeister M; Timofeeva M; Farrington S; Dunlop M; Brenner H
Clin Transl Gastroenterol; 2019 Dec; 10(12):e00106. PubMed ID: 31800541
[TBL] [Abstract][Full Text] [Related]
23. Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China.
Zhang GM; Zhu Y; Chen HT; Han CT; Liu F; Xu JF; Ye DW
Medicine (Baltimore); 2015 Oct; 94(42):e1603. PubMed ID: 26496266
[TBL] [Abstract][Full Text] [Related]
24. Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.
Yu H; Shi Z; Wu Y; Wang CH; Lin X; Perschon C; Isaacs WB; Helfand BT; Lilly Zheng S; Duggan D; Mo Z; Lu D; Xu J
Prostate; 2019 Jul; 79(10):1099-1105. PubMed ID: 31037745
[TBL] [Abstract][Full Text] [Related]
25. Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy?
Elshafei A; Moussa AS; Hatem A; Ethan V; Panumatrassamee K; Hernandez AV; Jones JS
Urology; 2013 Apr; 81(4):826-30. PubMed ID: 23434102
[TBL] [Abstract][Full Text] [Related]
26. Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
Chen H; Na R; Packiam VT; Conran CA; Jiang D; Tao S; Yu H; Lin X; Meng W; Zheng SL; Brendler CB; Helfand BT; Xu J
Prostate; 2017 Aug; 77(11):1179-1186. PubMed ID: 28670847
[TBL] [Abstract][Full Text] [Related]
27. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
[TBL] [Abstract][Full Text] [Related]
28. Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.
Zheng J; Liu F; Lin X; Wang X; Ding Q; Jiang H; Chen H; Lu D; Jin G; Hsing AW; Shao Q; Qi J; Ye Y; Wang Z; Gao X; Wang G; Chu LW; Ouyang J; Huang Y; Chen Y; Gao Y; Shi R; Wu Q; Wang M; Zhang Z; Hu Y; Sun J; Zheng SL; Gao X; Xu C; Mo Z; Sun Y; Xu J
Prostate; 2012 Apr; 72(5):577-83. PubMed ID: 21796652
[TBL] [Abstract][Full Text] [Related]
29. PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer.
Kaplan SA; Roehrborn CG; Meehan AG; Liu KS; Carides AD; Binkowitz BS; Heyden NL; Vaughan ED
Urology; 2009 May; 73(5):935-9. PubMed ID: 19328538
[TBL] [Abstract][Full Text] [Related]
30. Alcohol intake increases high-grade prostate cancer risk among men taking dutasteride in the REDUCE trial.
Fowke JH; Howard L; Andriole GL; Freedland SJ
Eur Urol; 2014 Dec; 66(6):1133-8. PubMed ID: 24568894
[TBL] [Abstract][Full Text] [Related]
31. Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.
Ren S; Xu J; Zhou T; Jiang H; Chen H; Liu F; Na R; Zhang L; Wu Y; Sun J; Yang B; Gao X; Zheng SL; Xu C; Ding Q; Sun Y
Prostate; 2013 Dec; 73(16):1824-35. PubMed ID: 24037738
[TBL] [Abstract][Full Text] [Related]
32. Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score.
Helfand BT; Chen H; Fantus RJ; Conran CA; Brendler CB; Zheng SL; Walsh PC; Isaacs WB; Xu J
Prostate; 2018 Jun; ():. PubMed ID: 29923209
[TBL] [Abstract][Full Text] [Related]
33. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O
Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men.
Turner AR; Lane BR; Rogers D; Lipkus I; Weaver K; Danhauer SC; Zhang Z; Hsu FC; Noyes SL; Adams T; Toriello H; Monroe T; McKanna T; Young T; Rodarmer R; Kahnoski RJ; Tourojman M; Kader AK; Zheng SL; Baer W; Xu J
Cancer; 2016 Nov; 122(22):3564-3575. PubMed ID: 27433786
[TBL] [Abstract][Full Text] [Related]
35. Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.
Mastalski K; Coups EJ; Ruth K; Raysor S; Giri VN
Cancer; 2008 Nov; 113(9):2559-64. PubMed ID: 18816608
[TBL] [Abstract][Full Text] [Related]
36. Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.
Seibert TM; Garraway IP; Plym A; Mahal BA; Giri V; Jacobs MF; Cheng HH; Loeb S; Helfand BT; Eeles RA; Morgan TM
Eur Urol; 2023 Mar; 83(3):241-248. PubMed ID: 36609003
[TBL] [Abstract][Full Text] [Related]
37. Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride.
Dai JY; LeBlanc M; Goodman PJ; Lucia MS; Thompson IM; Tangen CM
Cancer Prev Res (Phila); 2019 Feb; 12(2):113-120. PubMed ID: 30538099
[TBL] [Abstract][Full Text] [Related]
38. [Prostate Cancer Prevention Trial risk calculator for evaluating the risk of prostate cancer in the high-risk Chinese population].
Zhu XD; Zheng A; Wang ZQ; Shao Q
Zhonghua Nan Ke Xue; 2018 Feb; 24(2):142-146. PubMed ID: 30156074
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
[TBL] [Abstract][Full Text] [Related]
40. The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.
Benafif S; Ni Raghallaigh H; McGrowder E; Saunders EJ; Brook MN; Saya S; Rageevakumar R; Wakerell S; James D; Chamberlain A; Taylor N; Hogben M; Benton B; D'Mello L; Myhill K; Mikropoulos C; Bowen-Perkins H; Rafi I; Ferris M; Beattie A; Kuganolipava S; Sevenoaks T; Bower J; Kumar P; Hazell S; deSouza NM; Antoniou A; Bancroft E; Kote-Jarai Z; Eeles R
BJU Int; 2022 Mar; 129(3):325-336. PubMed ID: 34214236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
